Background: Early and accurate detection of acute myocardial infarction (AMI) is an important unmet clinical requirement. The present study sought to evaluate the levels of N-terminal pro-brain natriuretic peptide (NTproBNP), cardiac troponin I (cTnI), fasting lipid profile, random blood sugar, and serum creatinine in AMI patients compared to angina patients. Methods: In a single-center, hospital-based, cross-sectional, observational, prospective study conducted at Gandhi Medical College, Secunderabad, from October-2018 to September-2019. A total of 150 patients aged above 40 years with acute chest pain (within 2-6 hours) and who were clinically susceptive of AMI and angina were investigated. The patients were divided into group I (50 AMI patients) and group II (100 angina patients). Levels of all biochemical parameters of blood were assessed. The statistical analyses were performed using the SPSS statistical software, version 15. A student t-test was used to compare the continuous variables between the two groups. Results: Out of 150 patients, higher male prevalence was found in both the groups (60% and 63%, respectively). Group I had higher levels of NTproBNP (2909±273pg/ml vs. 110±20.74pg/ml, P<0.01), cTnI (2.06±1.3ng/ml vs. 0.006±0.002ng/ml, P<0.01), and fasting lipid profile (total cholesterol:216±41.2mg/dl vs.201±32.5mg/dl, P<0.05, triglycerides:217.7±63.6 mg/dl vs. 175.3±48.8 mg/dl, P<0.01, low-density lipoprotein:141.7mg/dl±41.5 vs. 127.1±30.24 mg/dl, P<0.05, very low-density lipoprotein:43.4±12.8mg/dl vs. 35.1±9.8mg/dl, P<0.01) than group II, except low levels of high-density lipoprotein (31.2±3.83mg/dl vs. 38.9±4.32 mg/dl, P<0.01). Conclusion: Assessment of NTproBNP, cTnI, and fasting lipid profile may aid in the early diagnosis of AMI and its management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.